title: Reply of the authors.
authors.forename: Amir
authors.initials: A
authors.lastname: Horev
authors.forename: Alon
authors.initials: A
authors.lastname: Haim
authors.forename: Alex
authors.initials: A
authors.lastname: Zvulunov
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D011433:Propranolol / Q000009:adverse effects*
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol